BOT 1.43% 34.5¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-5792

  1. 2,130 Posts.
    lightbulb Created with Sketch. 1508
    Mate, I hear you and have been a little nervous myself whilst we patiently wait, but we are on a winner here with BOT - the only question is timeframe. And by that, I mean a month or two vs one, maybe two years. If we don't get taken out immediately following FDA approval, then we will go to market and demonstrate SB's sales potential. That might take a year, but the longer it goes on the more the price goes up for Matt (due to demonstrated success) I would suggest. Self-funding the rest of the pipeline to Ph3 and FDA approval (2-3 years timeframe) is our worst case scenario I believe, and that's not a bad scenario!
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.